News

psioxus
Oct 5 , 2016

Bristol-Myers Squibb and PsiOxus Therapeutics Announce Clinical Collaboration

Bristol-Myers Squibb and PsiOxus Therapeutics announced an exclusive clinical collaboration agreement to evaluate the safety, tolerability, and preliminary efficacy of PsiOxus' enadenotucirev in combination with...


dollars
Oct 5 , 2016

Share and share alike! How do stakeholders make money from spinouts?

In this next feature looking at spinout companies, David Coleman, Head of Enterprise Acceleration, will cover some of the financial benefits associated with being a spinout company shareholder.  For example, how are...


why
Apr 5 , 2016

University Spinouts? What’s all the fuss about?

So you've got an idea for a product or service and you want to set up a new company?  Who do you turn to?  What's involved?  What are the options? How do we make it happen? In this first in a new series of features...


cancer cell
Feb 22 , 2016

Birmingham Spinout, Revitope Oncology, Inc. Raises $8.5 Million to Continue Development of Novel Cancer Immunotherapy Platform

Image courtesy of dream designs at FreeDigitalPhotos.net University of Birmingham spinout, Revitope Oncology, Inc. has raised $8.5 million to continue development of its novel immunotherapy platform for the treatment of...


PAGE 1 OF 5